Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

The cream effectively treats scalp psoriasis, improving symptoms and quality of life, with high patient satisfaction.

These new skin treatments are safer and more effective with minimal side effects.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Injectable platelet-rich fibrin can safely and effectively treat melasma.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Mesalazine showed limited effectiveness in treating children with severe alopecia areata.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Dupilumab may help regrow hair in people with atopic dermatitis.

The combined treatment increased hair density in most patients with Androgenetic Alopecia.

Ritlecitinib can help about 14,000 people with severe hair loss.

New findings suggest potential treatments for melanoma, hyperpigmentation, hair defects, and multiple sclerosis, and show skin microbiome changes don't cause atopic dermatitis.

Applying a specific inhibitor lightens skin and hair color.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Baricitinib successfully treated severe hair loss.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

Combining microneedling with either vitamin D3 or bimatoprost improves hair regrowth more than microneedling alone.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Baricitinib significantly regrows hair in severe alopecia areata patients.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

MPZL3 protein helps keep sebaceous gland size and cell growth in check.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Dupilumab effectively controls symptoms in infants with Netherton syndrome.